Skip to main content
. 2012 May 9;460(6):621–628. doi: 10.1007/s00428-012-1240-0

Table 2.

Clinical data

Case No Sex/Age Primary Site Size (cm) Therapy Follow-up (months) Rec (Met)
MEC
1 F/36 years na/sc 4.5 R0 NA
2 F/21 years Thigh/deep 5.0 R0 70, NER
3 F/53 years Vulva/exophytic 3.5 R0 60, NER
4 F/75 years Vulva 3.5 R0 34, NER
5 M/36 years Forearm/deep 10 R0 8, DOD Lung
6 F/15 years Neck/deep 4 R2 85, AWD 2 rec
7 M/15 years Sacral/deep 5 R0 39, NER
8 M/17 years Calf/deep 12 R0, perf,amp 8, DOD Bone, lung, LN
9 M/71 years Buttock/sc 15 R1 4, AWD Lung, LN
10 M/76 years Hand/deep, bone invasion 4.5 RM 12, NER 1 rec
EMC
11 M/61 years Thigh/deep 8.1 R0 12, NER
12 M/58 years Thigh/deep 10 R0 6, NER
13 F/37 years Shoulder/sc, deep 15 NT 6, AWD LN
14 M/82 years Paravertebral/cervical NA RX NA
15 F/46 years Ankle 1 RM 220, AWD 4 rec, lung

Mos months, Rec recurrence, Met metastases, Sc subcutis, LN lymph node, NER no evidence of recurrence, AWD alive with disease, DOD death of disease, NA not available, NT no treatment, Perf limb perfusion, Amp amputation, R0 complete resection, RM marginal resection, R1 resection with histological positive margins, R2 resection with macroscopically positive margins, RX resection with unknown margins